Recursion Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-06 09:37:44 ET RXRX

Published on 05/06/2026 at 09:37 am EDT

Recursion Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was USD 6.3 million compared to USD 14.82 million a year ago. Revenue was USD 6.47 million compared to USD 14.75 million a year ago.

Net loss was USD 117.5 million compared to USD 202.49 million a year ago. Basic loss per share from continuing operations was USD 0.22 compared to USD 0.5 a year ago. Diluted loss per share from continuing operations was USD 0.22 compared to USD 0.5 a year ago.